G
Geneplus-Beijing
A leading distributor company in the biotechnology and molecular diagnostic market in Thailand
About Geneplus-Beijing
Gene Plus is a professional distributor company operating in the biotechnology sector, specifically in the field of genetic sequencing and analysis. Based in Bangkok, the company provides innovative life science solutions to a variety of clients, including research institutions, forensic labs, and other organizations that require advanced genetic analysis.
The company's flagship product line is the Ion GeneStudio S5 Series, a range of genetic sequencers that share the same foundational technology and fluidic architecture. These devices differ primarily in their on-sequencer analysis time, allowing clients to choose the model that best suits their needs.
Gene Plus also offers the Genetic Analyzer for HID, a product developed by Thermo Fisher Scientific. This device provides end-to-end workflows for forensic DNA analysis, helping to solve complex cases and provide investigative leads in a forensically responsible manner.
Another key offering is the Rapid DNA Solutions, a system that significantly reduces the time required for DNA testing. This system can generate forensic DNA profiles in as little as 90 minutes, making it a valuable tool for crime prevention and investigation.
Additionally, Gene Plus distributes Hamilton Storage sample management systems, which are designed to integrate with Hamilton Robotics liquid handling workstations. These systems support a broad range of applications, including decapping, reading, and centrifuging.
Gene Plus generates revenue through the sale and distribution of these products. The company's business model is centered on providing high-quality, innovative solutions to its clients, backed by unparalleled support and continued innovation.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Bangkok, Thailand
- Employees
- 11
- Open positions
- None listed
- Dealroom signal
- 33.8/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Jul 2021 | $103M | $413M | Shengyu Investment · Jinmao Capital · Notable Capital · Baidu Ventures | — |
| SERIES BOther financing | Jan 2019 | $6.9M | $28M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Geneplus-Beijing is 1.9K monthly website visits, down 68.9% over the last three months. Geneplus-Beijing's team declined 15.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Geneplus-Beijing in the Bangkok ecosystem
The Geneplus-Beijing office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Green Pine Capital
Series B and later5 investors entered at this stage
CCB International- SIShengyu Investment
- JCJinmao Capital
Notable CapitalBaidu Ventures
Other known investors1 additional known investor
Volcanics Venture
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Geneplus-Beijing on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Geneplus-Beijing’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









